Stempoint Capital »

Avalo Therapeutics Ord shares owned by Stempoint Capital

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5M 136k 18.16

More positions owned by Stempoint Capital

Abivax Sa Sponsored Ads (ABVX)
Scholar Rock Hldg Corp (SRRK)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Syndax Pharmaceuticals (SNDX)
Structure Therapeutics Sponsored Ads (GPCR)
Arcellx Common Stock (ACLX)
Roivant Sciences SHS (ROIV)
Terns Pharmaceuticals (TERN)
Twist Bioscience Corp (TWST)
Immunovant (IMVT)
Dyne Therapeutics (DYN)
Xenon Pharmaceuticals (XENE)
Surrozen Com New (SRZN)
Celcuity (CELC)
Mineralys Therapeutics (MLYS)

View all positions for Stempoint Capital

Top funds holding Avalo Therapeutics Ord

BVF
Nantahala Capital Management
OrbiMed Advisors
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
RA Capital Management
Point72 Asset Management
Silverarc Capital Management
Marshall Wace
Citadel Advisors
Commodore Capital
TCG Crossover Management
UBS Group

View all funds holding Avalo Therapeutics Ord